Cargando…

How cutaneous leishmaniasis and treatment impacts in the patients’ lives: A cross-sectional study

BACKGROUND: Until now, few studies have evaluated the effect of cutaneous leishmaniasis (CL) on patients' quality of life, and none have used a specific instrument to measure this effect. The objective of this study was to identify factors that may be associated with the high impact of CL and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galvão, Endi Lanza, Pedras, Mariana Junqueira, Cota, Gláucia Fernandes, Rabello, Ana, Simões, Taynãna César
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347173/ https://www.ncbi.nlm.nih.gov/pubmed/30682151 http://dx.doi.org/10.1371/journal.pone.0211374

Ejemplares similares

Development and initial validation of a cutaneous leishmaniasis impact questionnaire
por: Galvão, Endi Lanza, et al.
Publicado: (2018)

Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis
por: Galvão, Endi Lanza, et al.
Publicado: (2017)

Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review
por: Brito, Nayara Castelano, et al.
Publicado: (2017)

Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial
por: Ramalho, Dario Brock, et al.
Publicado: (2018)

Estimating direct costs of the treatment for mucosal leishmaniasis in Brazil
por: Carvalho, Janaína de Pina, et al.
Publicado: (2021)

Inequalities of visceral leishmaniasis case-fatality in Brazil: A multilevel modeling considering space, time, individual and contextual factors
por: Cota, Gláucia, et al.
Publicado: (2021)

Intralesional infiltration versus parenteral use of meglumine antimoniate for treatment of cutaneous leishmaniasis: A cost-effectiveness analysis
por: Brito, Nayara C., et al.
Publicado: (2019)

The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-Analysis
por: Cota, Gláucia Fernandes, et al.
Publicado: (2016)

Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre
por: da Silva, Rosiana Estéfane, et al.
Publicado: (2016)

Serology for visceral leishmaniasis: How trusty is the accuracy reported by the manufacturers?
por: Freire, Mariana Lourenço, et al.
Publicado: (2023)

Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment
por: da Silva, Rosiana Estéfane, et al.
Publicado: (2018)

The Diagnostic Accuracy of Serologic and Molecular Methods for Detecting Visceral Leishmaniasis in HIV Infected Patients: Meta-Analysis
por: Cota, Gláucia Fernandes, et al.
Publicado: (2012)

Predictors of Visceral Leishmaniasis Relapse in HIV-Infected Patients: A Systematic Review
por: Cota, Gláucia F., et al.
Publicado: (2011)

Cost-effectiveness of serological tests for human visceral leishmaniasis in the Brazilian scenario
por: Freire, Mariana Lourenço, et al.
Publicado: (2020)

Diagnostic performance of commercially available COVID-19 serology tests in Brazil
por: Cota, Gláucia, et al.
Publicado: (2020)

Evaluation of a new brand of immunochromatographic test for visceral leishmaniasis in Brazil made available from 2018
por: Freire, Mariana Lourenço, et al.
Publicado: (2018)

Performance differences among commercially available antigen rapid tests for COVID-19 in Brazil
por: Freire, Mariana Lourenço, et al.
Publicado: (2022)

Efficacy of Anti-Leishmania Therapy in Visceral Leishmaniasis among HIV Infected Patients: A Systematic Review with Indirect Comparison
por: Cota, Gláucia F., et al.
Publicado: (2013)

Performance of serological tests available in Brazil for the diagnosis of human visceral leishmaniasis
por: Freire, Mariana Lourenço, et al.
Publicado: (2019)

Visceral Leishmaniasis and HIV Coinfection in Latin America
por: Lindoso, José Angelo, et al.
Publicado: (2014)

Anti-mitochondrial Tryparedoxin Peroxidase Monoclonal Antibody-Based Immunohistochemistry for Diagnosis of Cutaneous Leishmaniasis
por: Freire, Mariana Lourenço, et al.
Publicado: (2022)

Immune Activation and Bacterial Translocation: A Link between Impaired Immune Recovery and Frequent Visceral Leishmaniasis Relapses in HIV-Infected Patients
por: Silva-Freitas, Maria Luciana, et al.
Publicado: (2016)

Patients’ preferences of cutaneous leishmaniasis treatment outcomes: Findings from an international qualitative study
por: Erber, Astrid C., et al.
Publicado: (2020)

Diagnosis of visceral and cutaneous leishmaniasis using loop-mediated isothermal amplification (LAMP) protocols: a systematic review and meta-analysis
por: Erber, Astrid Christine, et al.
Publicado: (2022)

Economic evaluations addressing diagnosis and treatment strategies for neglected tropical diseases: an overview
por: de Assis, Tália Machado, et al.
Publicado: (2021)

An international qualitative study exploring patients’ experiences of cutaneous leishmaniasis: study set-up and protocol
por: Erber, Astrid Christine, et al.
Publicado: (2018)

Triphenylmethane Derivatives Have High In Vitro and In Vivo Activity against the Main Causative Agents of Cutaneous Leishmaniasis
por: de Souza Pietra, Renata Celi Carvalho, et al.
Publicado: (2013)

Cutaneous leishmaniasis mimicking cutaneous lymphoma
por: Pires, Carla Andréa Avelar, et al.
Publicado: (2019)

Factors Associated with Visceral Leishmaniasis in the Americas: A Systematic Review and Meta-Analysis
por: Belo, Vinícius Silva, et al.
Publicado: (2013)

Potential antigenic targets used in immunological tests for diagnosis of tegumentary leishmaniasis: A systematic review
por: Freire, Mariana Lourenço, et al.
Publicado: (2021)

Correction: Factors Associated with Visceral Leishmaniasis in the Americas: A Systematic Review and Meta-Analysis
por: Belo, Vinícius Silva, et al.
Publicado: (2013)

Impaired Thymic Output Can Be Related to the Low Immune Reconstitution and T Cell Repertoire Disturbances in Relapsing Visceral Leishmaniasis Associated HIV/AIDS Patients
por: Silva-Freitas, Maria Luciana, et al.
Publicado: (2020)

Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: A collaborative retrospective study
por: Castro, Maria del Mar, et al.
Publicado: (2023)

Cost-effectiveness of anti-SARS-CoV-2 antibody diagnostic tests in Brazil
por: de Assis, Tália Santana Machado, et al.
Publicado: (2022)

Impact of the presence of partially erupted third molars on the local radiographic bone condition
por: Fernandes, Ighor Andrade, et al.
Publicado: (2022)

Unusual Presentation of Cutaneous Leishmaniasis: Ocular Leishmaniasis
por: Doroodgar, Masoud, et al.
Publicado: (2017)

Recurrent cutaneous leishmaniasis*
por: Gomes, Ciro Martins, et al.
Publicado: (2013)

Zosteriform cutaneous leishmaniasis
por: Tin, Sim Sai, et al.
Publicado: (2014)

Biomarkers of Cutaneous Leishmaniasis
por: Bahrami, Fariborz, et al.
Publicado: (2018)

Risk factors for cutaneous leishmaniasis in the rainforest of Bolivia: a cross-sectional study
por: Eid, Daniel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t4kaj96e2hd73le2pa9se2mbao